Personalized Blood Test for Lung Cancer
June 21, 2022 | Terry Sharrer
“A new study funded by Cancer Research UK has shown that a personalised blood test can be used to identify the risk of lung cancer returning. Developed by biotech company Inivata, the liquid biopsy, called RaDaR, has the ability to pick up tiny fragments of DNA released into the blood as tumours grow. The Lung Cancer Circulating Tumour DNA (LUCID-DNA) study showed how circulating tumour DNA (ctDNA) is able to reveal a tumour’s state, location and weaknesses.” MORE
Image Credit: Cancer Research UK